Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation

Abstract

Objective5-Fluorouracil (5-Fu) has been widely used as a first-line drug for colorectal cancer (CRC) treatment but limited by drug resistance and severe toxicity. The chemo-sensitizers that augment its efficiency and overcome its limitation are urgently needed. Gypenosides (Gyp), the main components from Gynostemma pentaphyllum (Thunb.) Makino, has shown potential anti-tumor property with little side-effect. Here, we carefully explored the chemo-sensitization of Gyp to potentiate the anti-tumor effect of 5-Fu in vitro and in vivo.Methodology / Principal Findings3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltertrazolium bromide tetrazolium assay and colony formation test reveal that Gyp could significantly enhance the 5-Fu-caused SW-480,SW-620 and Caco2 cells viability loss. Calcusyn analysis shows that Gyp acts synergistically with 5-Fu. Annexin V-PE/7-AAD staining indicates 5-Fu + Gyp could induce SW-480 cell apoptosis. The activations of caspase 3, caspase 9 and poly (ADP-ribose) polymerase (PARP) were involved in the process. Gyp was also found to up-regulate 5-Fu-caused phospho-p53 expression and thus augment 5-Fu-induced G0/G1 phase arrest. Gyp elevated intracellular ROS level, significantly enhanced 5-Fu-triggered DNA damage response as evidenced by flow cytometry, comet assay and the expression of Ser139-Histone H2A.X. Inhibition of ROS and p53 respectively reversed the cell death induced by 5-Fu + Gyp, suggesting the key roles of ROS and p53 in the process. Moreover, 5-Fu and Gyp in combination exhibits much superior tumor volume and weight inhibition on CT-26 xenograft mouse model in comparison to 5-Fu or Gyp alone. Immunohistochemistry analysis suggests the combinations greatly suppressed tumor proliferation. Preliminary toxicological results show that 5-Fu + Gyp treatment is relatively safe.ConclusionsAs a potential chemo-sensitizer, Gyp displays a splendid synergistic effect with 5-Fu to inhibit cancer cell proliferation and tumor growth. By using 5-Fu and Gyp in combination would be a promising therapeutic strategy for CRC treatment.

Lidocine potentiates the cytotoxicity of 5‐fluorouracil to choriocarcinoma cells by downregulating ABC transport proteins expression

“…Combination therapy is an efficient therapeutic strategy for cancer treatment . Herein, we found that high concentration of lidocaine caused choriocarcinoma cell apoptosis s through lowering Bax, cleaved‐caspase‐3 and cleaved‐caspase‐9.…”

Therapeutic Effect of Gypenosides on Nonalcoholic Steatohepatitis <i>via</i> Regulating Hepatic Lipogenesis and Fatty Acid Oxidation

“…However, there are currently no efficient pharmaceutical therapeutics for NASH. 14) Therefore, the exploration of an appropriate pharmacological therapy for NASH is important. Herbal treatment for NAFLD has received increasing attention in recent decades due to its wide availability, minimal side effects, and proven therapeutic mechanisms and benefits.…”

“…MAKINO is a cucurbitaceous herbaceous vine that is widely used in traditional medicine in China and other Asian countries for the treatment of cancer, hyperlipoproteinemia, hepatitis, and cardiovascular disease. 15) Gypenosides, the major active component extract from G. pentaphyllum (THUNB.) MAKINO, exist mainly as dammaranetype triterpene glycosides and possess a number of pharmacological properties, including anti-aging, cardioprotective, and neuroprotective effects.…”

Inhibition of phosphoserine phosphatase enhances the anticancer efficacy of 5-fluorouracil in colorectal cancer

“…5-FU was previously shown to induce the formation of ROS, which cause damage to nucleotides, lipids, and proteins, thereby promoting cell death [9,10]. Consequently, the elimination of 5-FU-stimulated ROS could be critical for cancer cell survival.…”